Daniel Dolan

Business address
C/O Nabriva Therapeutics Plc, 1000 Continental Drive, Suite 600, King Of Prussia, PA, 19406
Top holdings (ownership)
NBRV
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Daniel Dolan has filed 6 SEC EDGAR filings since 06 Oct 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT 15 Aug 2022 11 Aug 2022 001-37558
4 Open Document Open Filing OWNERSHIP DOCUMENT 01 Feb 2022 28 Jan 2022 001-37558
4 Open Document Open Filing OWNERSHIP DOCUMENT 02 Apr 2021 31 Mar 2021 001-37558
3 Open Document Open Filing OWNERSHIP DOCUMENT 16 Mar 2021 12 Mar 2021 001-37558
4 Open Document Open Filing FORM 4 SUBMISSION 10 Nov 2020 09 Nov 2020 001-35726
3 Open Document Open Filing FORM 3 SUBMISSION 06 Oct 2020 24 Sep 2020 001-35726